| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely nifedipine 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| pseudoefedrin 240 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| amoxicillin 1 g + kaliumklavulanat 62,5 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| diltiazem 240 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| trandolapril 2 mg + verapamilhydroklorid 240 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely dihydrocodeine tartrate 90 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Sodium valproate 200 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| isosorbidmononitrat 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Nisoldipine 10 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| kinidinglukonat 324 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Ibuprofen 800 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Oxycodone hydrochloride 5 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| etodolak 500 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| zolpidem 12,5 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely oxycodone hydrochloride 15 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| azatadinmaleat 1 mg + pseudoefedrinsulfat 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| guajfenesin 600 mg + dextrometorfan 30 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely methylphenidate hydrochloride 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| glipizid 10 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely mizolastine 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| prokainamidhydroklorid 750 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| bupropionhydroklorid 50 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely bezafibrate 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| takrolimus 1 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| oximorfon 40 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| lovastatin 40 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| bromfeniraminmaleat 16 mg + pseudoefedrinhydroklorid 240 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely dexbrompheniramine maleate 6 milligram and pseudoephedrine sulfate 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Nifedipine 60 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely theophylline 175 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| nisoldipin 40 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| karbidopa (som karbidopamonohydrat) 50 milligram och levodopa 200 milligram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely doxazosin (as doxazosin mesilate) 8 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| naproxennatrium 200 mg + pseudoefedrin 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| ciprofloxacin 500 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Morphine sulfate 60 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely pyridostigmine bromide 180 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| vattenfritt teofyllin 450 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| trandolapril 4 mg + verapamilhydroklorid 240 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| metoprololsuccinat 200 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Tramadol hydrochloride 200 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| vattenfritt teofyllin 300 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Metformin hydrochloride 750 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely dihydrocodeine tartrate 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| karbinoxaminmaleat 8 mg + pseudoefedrinhydroklorid 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Sodium valproate 300 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Lithium carbonate 450 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| diltiazem 360 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| trandolapril 2 mg + verapamilhydroklorid 180 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| aminofyllin 100 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| ciprofloxacin 1 000 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely pentoxifylline 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely nifedipine 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely oxycodone hydrochloride 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 36 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely morphine sulfate 15 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| lovastatin 10 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| lovastatin 60 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| belladonnaalkaloider 0,2 mg + ergotamintartrat 0,6 mg + fenobarbital 40 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Isosorbide mononitrate 50 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| aminofyllin 225 milligram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| metamfetaminhydroklorid 5 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| naproxennatrium 220 mg + pseudoefedrin 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 54 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| metamfetaminhydroklorid 15 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| järn(II)sulfat 160 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely methylphenidate hydrochloride 27 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Tramadol hydrochloride 75 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Nisoldipine 20 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| oximorfon 10 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely isosorbide dinitrate 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| desloratadin 5 mg + pseudoefedrin 240 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| verapamilhydroklorid 180 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely dihydrocodeine tartrate 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| metylfenidathydroklorid 10 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Codeine phosphate 20 mg and ibuprofen 300 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| metoprololsuccinat 100 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Oxycodone hydrochloride 60 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Morphine sulfate 5 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| zolpidem 6,25 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely verapamil hydrochloride 240 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely lithium carbonate 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| diltiazem 420 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely doxazosin (as doxazosin mesilate) 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Terbutaline sulfate 7.5 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Diltiazem hydrochloride 60 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Oxycodone hydrochloride 30 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Diltiazem hydrochloride 90 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| oximorfon 20 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| aminofyllin 350 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 630 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| pioglitazon 30 mg + metformin 1 g, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely morphine sulfate 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| enalaprilmaleat 5 mg + felodipin 5 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely potassium chloride 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Product containing precisely mesalazine 500 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
| Metformin hydrochloride 1 g prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|